首页> 外国专利> Preparing bromo-dimethyl-dihydro-indole, useful to prepare dimethyl-(trifluoromethyl)phenyl-dihydro-indol-ylsulfonyl-methylphenoxy acetic acid, comprises reacting dimethyl-dihydro-indol-ethanone with a brominating reagent and transforming

Preparing bromo-dimethyl-dihydro-indole, useful to prepare dimethyl-(trifluoromethyl)phenyl-dihydro-indol-ylsulfonyl-methylphenoxy acetic acid, comprises reacting dimethyl-dihydro-indol-ethanone with a brominating reagent and transforming

机译:制备可用于制备二甲基-(三氟甲基)苯基-二氢-吲哚-磺酰基-甲基苯氧基乙酸的溴-二甲基-二氢吲哚,包括使二甲基-二氢-吲哚-乙酮与溴化试剂反应并转化。

摘要

Preparing 5-bromo-3,3-dimethyl-2,3-dihydro-1H-indole (I) and its salt, comprises reacting 1-(3,3-dimethyl-2,3-dihydro-indol-1-yl)-ethanone in a solvent with a brominating reagent and subsequently optionally transforming into the salt form. Independent claims are included for: (1) preparing [4-(chlorosulfonyl)-2-methylphenoxy]acetic acid ethyl ester (II) comprising reacting (2-methylphenoxy)acetic acid ethylester in a solvent with chlorosulfonic acid; (2) preparing {4-[(5-bromo-3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)sulfonyl]-2-methylphenoxy}acetic acid ethylester (III) comprising reacting (II) in a solvent mixture with 5-bromo-3,3-dimethyl-2,3-dihydro-1H-indole hydrochloride and optionally recrystallizing in a solvent or its mixture; (3) preparing {4-[(3,3-dimethyl-5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-indol-1-yl)sulfonyl]-2-methylphenoxy}acetic acid ethylester (IV) comprising reacting (III) in a solvent mixture at reflux in the presence of a catalyst system, consisting of a palladium species, a phosphine ligand and a base with 4-(trifluoromethyl)phenylboronic acid; and (4) preparing {4-[(3,3-dimethyl-5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-indol-1-yl)sulfonyl]-2-methylphenoxy}acetic acid (V)comprising reacting (IV) in a solvent mixture at 50[deg] C in the presence of a phase transfer catalyst with a base and optionally recrystallizing the solvent or its mixture. ACTIVITY : Cardiovascular-Gen; Antilipemic; Antiarteriosclerotic; Cardiant; Vasotropic. MECHANISM OF ACTION : Peroxisome proliferated-activated receptor delta activator.
机译:制备5-溴-3,3-二甲基-2,3-二氢-1H-吲哚(I)及其盐包括使1-(3,3-二甲基-2,3-二氢-吲哚-1-基)反应。 -乙酮在溶剂中与溴化试剂混合,随后任选转化为盐形式。包括以下独立权利要求:(1)制备[4-(氯磺酰基)-2-甲基苯氧基]乙酸乙酯(II),包括使(2-甲基苯氧基)乙酸乙酯在溶剂中与氯磺酸反应; (2)制备{4-[(5-溴-3,3-二甲基-2,3-二氢-1H-吲哚-1-基)磺酰基] -2-甲基苯氧基}乙酸乙基酯(III),包括使(II)反应)在与5-溴-3,3-二甲基-2,3-二氢-1H-吲哚盐酸盐的溶剂混合物中,并任选地在溶剂或其混合物中重结晶; (3)制备{4-[(3,3-二甲基-5- [4-(三氟甲基)苯基] -2,3-二氢-1H-吲哚-1-基)磺酰基] -2-甲基苯氧基}乙酸乙酯(IV)包括使(III)在溶剂混合物中,在由钯物质,膦配体和碱组成的催化剂体系的存在下,与4-(三氟甲基)苯基硼酸反应; (4)制备{4-[((3,3-二甲基-5- [4-(三氟甲基)苯基] -2,3-二氢-1H-吲哚-1-基)磺酰基] -2-甲基苯氧基}乙酸(V)包括在相转移催化剂的存在下,在溶剂混合物中使(IV)在50℃下与碱反应,并且任选地使溶剂或其混合物重结晶。活动:心血管生成;抗血脂;抗动脉硬化;卡迪恩变压的。作用机理:过氧化物酶体增殖激活受体δ激活剂。

著录项

  • 公开/公告号DE102006059314A1

    专利类型

  • 公开/公告日2008-06-19

    原文格式PDF

  • 申请/专利权人 BAYER HEALTHCARE AG;

    申请/专利号DE20061059314

  • 申请日2006-12-15

  • 分类号C07D209/08;C07C309/89;A61K31/404;A61P9;A61P9/10;

  • 国家 DE

  • 入库时间 2022-08-21 19:49:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号